Oklahoma Cancer Specialists and Research Institute is a clinical research site located in Tulsa, Oklahoma, United States 74146.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Oklahoma Cancer Specialists and Research Institute has participated in 20 clinical trials with 11 currently active.
Therapeutic areas: Immune Thrombocytopenia, Blood Platelet Disorder, Hematologic Diseases.
Sponsors: Hutchmed, Novartis Pharmaceuticals, EMD Serono Research & Development Institute, Inc..
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Oklahoma Cancer Specialists and Research Institute has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oklahoma Cancer Specialists and Research Institute has 20 clinical trials on record, with 11 currently active. Their work covers Immune Thrombocytopenia, Blood Platelet Disorder, Hematologic Diseases.
Yes — Oklahoma Cancer Specialists and Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.